Results 201 to 210 of about 82,606 (343)

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, EarlyView.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source

CAI Score for the Diagnosis of Central Adrenal Insufficiency. [PDF]

J Endocr Soc
Almalki MH, Saygili ES, Aboalsamh N, Alghassab A, Alshammari Y, Alali F, Alghufaili S, Alshehri H, Alshahrani A, Elhassan YS.   +9 more
europepmc   +1 more source

Chronic primary adrenal insufficiency

, 2010
Jeremy Jones, Tim Luijkx, Yuranga Weerakkody   +2 more
openalex   +1 more source

Steroidogenic compensation and lipid deficiency with enhanced NAD+ salvage in small‐for‐gestational‐age placenta

The FEBS Journal, EarlyView.
Fetal growth restriction is associated with placental metabolic adaptations. In small‐for‐gestational‐age placenta (SGA), cholesterol receptors and steroidogenic enzymes are upregulated, enhancing steroidogenesis. NAD salvage pathway is also increased to support NADP+/NADPH requirements.
Serena Xodo, Lorenza Driul, Vanessa Tolotto, Eros Di Giorgio, Luigi E. Xodo   +4 more
wiley   +1 more source

Adrenal Insufficiency due to Disseminated <i>Cryptococcus</i> in an Immunocompetent Individual. [PDF]

Case Rep Endocrinol
Knott JA, Apostoloski Z.
europepmc   +1 more source

Endocrinology of the hypothalamus and the pituitary gland [PDF]

, 1973
Kuhlendahl, Hans, Scriba, Peter Christian   +1 more
core   +1 more source

What's the most practical way to rule out adrenal insufficiency?

, 2009
Thomas Satre, Fran E. Kovach
openalex   +1 more source

Efficacy and Safety of Second‐Line Lenvatinib After First‐Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma

Hepatology Research, EarlyView.
ABSTRACT Background There is a paucity of data regarding the efficacy and safety of lenvatinib as a second‐line treatment following first‐line combination immunotherapy with durvalumab and tremelimumab (Dur + Tre). Methods This retrospective multicenter study included 14 patients with unresectable hepatocellular carcinoma who received lenvatinib after ...
Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda, Aiko Tanaka, Kou Hashimoto, Tomoaki Emori, Yasutoshi Fujii, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Daiki Miki, Shinsuke Uchikawa, Nami Mori, Keiji Tsuji, Yosuke Suehiro, Keiichi Masaki, Michihiro Nonaka, Kenji Yamaoka, Yoshio Katamura, C. Nelson Hayes, Masataka Tsuge, Shiro Oka   +21 more
wiley   +1 more source

ADRENAL INSUFFICIENCY [PDF]

Endocrinology, 1921
openaire   +2 more sources

Addisonian Crisis in a 39-Year-Old Woman With Primary Adrenal Insufficiency. [PDF]

Cureus
Itteera MR, Gutierrez M, Patel KH.
europepmc   +1 more source